Evidence map›Paper›PMID 27164557›Full record

ArticleScientific reports2016

Genetic Relationship between Schizophrenia and Nicotine Dependence.

Jingchun Chen, Silviu-Alin Bacanu, Hui Yu, Zhongming Zhao, Peilin Jia, Kenneth S Kendler, Henry R Kranzler, Joel Gelernter, Lindsay Farrer, Camelia Minica and 12 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Transcriptomic Analysis of the Human Habenula in Schizophrenia.The American journal of psychiatry · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jingchun ChenNevada Institute of Personalized Medicine, University of Nevada at Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.
Silviu-Alin BacanuVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, VA 23298, USA.
Hui YuDepartments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Zhongming ZhaoDepartments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Peilin JiaDepartments of Biomedical Informatics and Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Kenneth S KendlerVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, VA 23298, USA.
Henry R KranzlerDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN4 MIRECC, Philadelphia VA Medical Center, Philadelphia, PA, USA.
Joel GelernterDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, and VA CT Healthcare Center, New Haven, CT 06516, USA.
Lindsay FarrerDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, MA, USA.
Camelia MinicaDepartment of Biological Psychology, VU University, Amsterdam, Netherlands.
Rene PoolDepartment of Biological Psychology, VU University, Amsterdam, Netherlands.
Yuri MilaneschiDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.
Dorret I BoomsmaDepartment of Biological Psychology, VU University, Amsterdam, Netherlands.
Brenda W J H PenninxDepartment of Biological Psychology, VU University, Amsterdam, Netherlands.
Rachel F TyndaleDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Jennifer J WareMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Jacqueline M VinkDepartment of Biological Psychology, Vrije Universiteit, Amsterdam, The Netherlands.
Jaakko KaprioUniversity of Helsinki, Department of Public Health, P.O.Box 41 (Mannerheimintie 172), 00014 Helsinki, Finland.
Marcus MunafòMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Xiangning ChenNevada Institute of Personalized Medicine, University of Nevada at Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.
Cotinine meta-analysis group
FTND meta-analysis group

Funding

Genes and molecular pathways in nicotine dependence and withdrawalR01DA032246 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, MILES, MICHAEL F · 2013 to 2017
$1.7M
Understanding the genetic architecture of schizophrenia in Chinese populationR01MH101054 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHEN, XIANGNING · 2013 to 2015
$602k
Medical Research Council MC_UU_12013/3Medical Research Council MC_UU_12013/5NIDA NIH HHS R01 DA032246NIMH NIH HHS R01 MH101054
6 · The paper itself

Abstract

It is well known that most schizophrenia patients smoke cigarettes. There are different hypotheses postulating the underlying mechanisms of this comorbidity. We used summary statistics from large meta-analyses of plasma cotinine concentration (COT), Fagerström test for nicotine dependence (FTND) and schizophrenia to examine the genetic relationship between these traits. We found that schizophrenia risk scores calculated at P-value thresholds of 5 × 10(-3) and larger predicted FTND and cigarettes smoked per day (CPD), suggesting that genes most significantly associated with schizophrenia were not associated with FTND/CPD, consistent with the self-medication hypothesis. The COT risk scores predicted schizophrenia diagnosis at P-values of 5 × 10(-3) and smaller, implying that genes most significantly associated with COT were associated with schizophrenia. These results implicated that schizophrenia and FTND/CPD/COT shared some genetic liability. Based on this shared liability, we identified multiple long non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), protein modification genes (MANBA, UBE2D3, and RANGAP1) and energy production genes (XYLB, MTRF1 and ENOX1) that were associated with both conditions. Further analyses revealed that these shared genes were enriched in calcium signaling, long-term potentiation and neuroactive ligand-receptor interaction pathways that played a critical role in cognitive functions and neuronal plasticity.

Indexed as

CotinineFemaleGene Regulatory NetworksGenome-Wide Association StudyHumansMalePolymorphism, Single NucleotideRisk AssessmentRisk FactorsSchizophreniaSignal TransductionTobacco Use DisorderCotinine

Identifiers

PMID27164557
PMCPMC4862382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.